Ads
related to: pharmaceutical drug companies
Search results
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
The Motley Fool via AOL· 5 hours agoThis year, one of its more promising drug candidates, inaxaplin, has entered late-stage trials to study its effectiveness as a treatment for...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 2 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Got $500? 3 Pharma Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 4 hours agoVertex Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) is worth buying today and holding forever because it has dominance in one...the market for...
Drug companies pay doctors over A$11 million a year for travel and education - EconoTimes
EconoTimes· 2 days agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas...
Lizzo reacts to being named an Ozempic alternative in “South Park” joke: 'I'm really that bitch'
Entertainment Weekly via Yahoo News· 2 hours agoIn recent months Lizzo has been mired in controversy, after three of her former backup dancers filed...
Medicare is negotiating drug prices. Here's why that matters
Scripps News via AOL· 2 days agoFor the first time, Medicare is negotiating the prices of some prescription drugs. Here's why that...
GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — 2nd Update
Morningstar· 5 days agoGSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds ($3.81 billion) closer ...
Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews.com
ETF DAILY NEWS· 13 hours agoStockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday.
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 2 days agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2,...
The Arab Tribune· 6 days agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused ...
